SCHEMBL12640232

SCHEMBL12640232

COc1ccc(C(C)=O)c(CO)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
NNMT P40261 3/20 0.49
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
HSD17B10 Q99714 3/20 0.40
TSHR P16473 2/20 0.40
ALDH1A1 P00352 3/20 0.40
CYP3A4 P08684 1/20 0.40
MAPK1 P28482 1/20 0.40
MTNR1A P48039 7/20 0.38
MTNR1B P49286 7/20 0.38
LMNA P02545 2/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HTT P42858 1/20 0.36
CYP1A2 P05177 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8443874 0.78 POLB (0.73) POLBTDP1NNMTRAB9ANPC1
SCHEMBL31141991 0.78 POLB (0.73) POLBTDP1NNMTRAB9ANPC1
SCHEMBL17150214 0.78 KDM4E (0.55) TDP1NNMTRAB9AHPGDSMN1; SMN2
SCHEMBL15308663 0.78 NNMT (0.71) POLBTDP1NNMTRAB9ANPC1
SCHEMBL16025487 0.76 POLB (0.51) POLBTDP1NNMTRAB9ANPC1
SCHEMBL27248156 0.76 POLB (0.51) POLBTDP1NNMTRAB9ANPC1
SCHEMBL30985306 0.75 TDP1 (0.58) POLBTDP1NNMTRAB9ANPC1
SCHEMBL24195300 0.74 TDP1 (0.62) POLBTDP1NNMTRAB9ANPC1
SCHEMBL28297760 0.74 TDP1 (0.62) POLBTDP1NNMTRAB9ANPC1
SCHEMBL7899408 0.73 PDE4A (0.41) POLBTDP1NNMTALDH1A1MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420827-B2 Thiazole derivatives KYOWA HAKKO KIRIN CO., LTD. (JP) 2013-04-16 US disclosed
US-20110105486-A1 THIAZOLE DERIVATIVES KYOWA HAKKO KIRIN CO., LTD. (JP) 2011-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105486-A1 THIAZOLE DERIVATIVES CHD8, CYP2C8, THRA POLB 3342/4885TDP1 4663/4885NNMT 2224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.